Last reviewed · How we verify
NCT05050747
Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle
trial testing HCG is introduced at day of trigger intra-uterine in Female Infertility in 402 participants. Completed in 12 November 2024.
25 August 2024
Quick facts
| Lead sponsor | Wael Elbanna Clinic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 402 |
| Start date | 27 September 2021 |
| Primary completion | 25 August 2024 |
| Estimated completion | 12 November 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- HCG is introduced at day of trigger intra-uterine — full drug profile →
- endometrial injury by pipelle
Conditions studied
- Female Infertility — all drugs for Female Infertility →
Sponsor
Wael Elbanna Clinic
Who can join
Adults 25 to 35, female only, with Female Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our study aims to describe the effect of the intrauterine adminstration of HCG versus the endometrial injury by pipelle on the ongoing pregnancy rate and the biochemical pregnancy rate in women with unexplained infertility undergoing ovulation induction. Also to describe the effect on the first trimester miscarriage rate, ectopic pregnancy rate, and multiple pregnancy.This study is an open-label, prospective, controlled study, multi-center study. The study participants' relevant medical records will be collected and reviewed after obtaining informed consent for the participants. The study materials that will be used will include blood tests, and ultrasound. The study will involve three study arms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05050747
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Female Infertility
Currently open trials in the same condition.
- NCT07500337 — Day-4 Embryo Defragmentation: Blastocyst Rate and clInical Outcomes · NA · recruiting
- NCT07394530 — Comparison of IVF Outcomes Between PPOS and Antagonist Protocols in Women With PCOS · NA · recruiting
- NCT07066267 — Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) · NA · recruiting
- NCT06896747 — Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study · Phase 1, PHASE2 · recruiting
- NCT06921395 — Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulat · Phase 4 · recruiting
Other Wael Elbanna Clinic trials
Trials by the same sponsor.
- NCT05154279 — The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and · NA · unknown
- NCT05170230 — The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic · NA · recruiting
- NCT05242783 — The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myome · NA · completed
- NCT05266534 — The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myome · NA · recruiting
- NCT05014867 — Comparative Study to Assess the Ongoing Pregnancy Rate for Poor Responders Women Undergoing Different Embryo Transfer Pr · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05050747 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wael Elbanna Clinic
- Last refreshed: 19 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05050747.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing